SecBot SecBot
8-K ·Filed Apr 22, 2026

SBCWW

SBC Medical Group Holdings Inc
NEUTRAL
Impact 4/10
Horizondays Processed6mo ago SEC0001493152-26-018603
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Actionable Insight • Neutral

Monitor for potential downward pressure on the stock price due to the large secondary offering, and watch for any future insider selling activity by the CEO. The company's lack of proceeds suggests this is purely a shareholder liquidity event rather than a capital raise.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
SBCWW ▼ -3.89% at T+60d
NEUTRAL call -3.89% · α vs SPY -8.90% · entry $0.2496 → $0.2399
Entry = T+0 close
Apr 22, 2026
via day close
T+1d
+0.01%
call +0.01% · α -0.77%
$0.2496
settled 6mo ago
T+5d
+0.01%
call +0.01% · α -1.47%
$0.2496
settled 6mo ago
T+20d
-0.01%
call -0.01% · α -4.65%
$0.2496
settled 5mo ago
T+60d
-3.89%
call -3.89% · α -8.90%
$0.2399
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

SBC Medical Group Holdings Inc. announced the sale of 3,100,000 shares by CEO Dr. Yoshiyuki Aikawa in an underwritten offering priced at $3.25 per share, raising approximately $10.1 million for the selling stockholder. The company did not receive any proceeds from the offering.

Key Financial Metrics

Deal Value
$10.1M

Key Facts

  • CEO and Chairman Dr. Yoshiyuki Aikawa sold 3,100,000 shares in an underwritten offering
  • Public offering price was $3.25 per share
  • Total gross proceeds to the selling stockholder were approximately $10.075 million
  • The company did not receive any proceeds from this offering
  • Underwriters have a 45-day option to purchase up to an additional 465,000 shares
  • The offering closed on April 21, 2026

Financial Impact

Approximately $10.1 million in gross proceeds to the selling stockholder at $3.25 per share

dilutionownership

Risk Factors

  • Potential negative market sentiment from insider selling by the CEO
  • Possible share price dilution and downward pressure from the large offering

Market Snapshot

Exchange
Nasdaq
Sector
Services-Offices & Clinics of Doctors of Medicine

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-018603
Document: form8-k.htm0001493152-26-018603
Document: 0001493152-26-018603-index-headers.html0001493152-26-018603
Document: 0001493152-26-018603-index.html0001493152-26-018603
Document: 0001493152-26-018603.txt0001493152-26-018603
3 reports for SBCWW
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for SBCWW — sortable, filterable
TypeNow
May 28, 2026
21w ago
DEFA14A
NEUTRAL ★ 3/10
$0.2496 $0.3349▲ +34.17%▲ +32.44%—
May 14, 2026
23w ago
8-K
BEARISH ★ 6/10
$0.2496 $0.2601▼ −4.21%▼ −0.62%—
Apr 22, 2026
26w ago
8-K
NEUTRAL ★ 4/10
$0.2496 $0.2399▼ −3.89%▼ −8.90%—
Showing 3 of 3

US Market Status

Market Open — Closes in 3h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 23, 2026